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Endothelial glycocalyx shields 
the interaction of SARS‑CoV‑2 
spike protein with ACE2 receptors
Marta Targosz‑Korecka1*, Agata Kubisiak1, Damian Kloska2, Aleksandra Kopacz2, 
Anna Grochot‑Przeczek2 & Marek Szymonski1
Endothelial cells (ECs) play a crucial role in the development and propagation of the severe COVID‑
19 stage as well as multiorgan dysfunction. It remains, however, controversial whether COVID‑19‑
induced endothelial injury is caused directly by the infection of ECs with SARS‑CoV‑2 or via indirect 
mechanisms. One of the major concerns is raised by the contradictory data supporting or denying 
the presence of ACE2, the SARS‑CoV‑2 binding receptor, on the EC surface. Here, we show that 
primary human pulmonary artery ECs possess ACE2 capable of interaction with the viral Spike 
protein (S‑protein) and demonstrate the crucial role of the endothelial glycocalyx in the regulation 
of the S‑protein binding to ACE2 on ECs. Using force spectroscopy method, we directly measured 
ACE2‑ and glycocalyx‑dependent adhesive forces between S‑protein and ECs and characterized the 
nanomechanical parameters of the cells exposed to S‑protein. We revealed that the intact glycocalyx 
strongly binds S‑protein but screens its interaction with ACE2. Reduction of glycocalyx layer exposes 
ACE2 receptors and promotes their interaction with S‑protein. These results indicate that the 
susceptibility of ECs to COVID‑19 infection may depend on the glycocalyx condition.
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) enters the host cell using the angiotensin-
converting enzyme 2 (ACE2)  receptors1–3. The virus attaches to cells via spike proteins (S-proteins). Structurally, 
S-proteins are glycoproteins that protrude from the viral surface and form a characteristic crown. S-protein 
consists of two subunits: S1 subunit that includes receptor-binding domain (RBD) and that recognizes and 
binds to the specific receptor; S2 subunit that regulates the membrane fusion between the virus and host  cells4. 
The interaction between S-protein and ACE2 has a pivotal role in virus pathogenesis. Therefore S-protein has 
been considered as a promising therapeutic target for the development of vaccines and antiviral compounds. 
Moreover, the high transmissibility of SARS-CoV-2 and the severity of COVID-19 is related to the high binding 
affinity of S-protein to ACE2  receptors5.
SARS-CoV-2 belongs to respiratory viruses, which are transmitted mainly through respiratory droplets. 
Therefore, airway epithelial cells are the main target that is initially exposed to contact with viruses and are 
responsible for the initiation of COVID-19 disease and development of severe acute respiratory  syndrome6–10. 
While the role of the airway epithelium is essential in the initial COVID-19 stage, the endothelium may play a 
crucial role in the development and propagation of the later severe COVID-19  stage5,11.
The strong inflammatory response induced by SARS-CoV-2 viruses causes endothelial dysfunction and pro-
motes severe cardiovascular complications such as venous thromboembolism, arrhythmias, and myocardial dys-
function, as evidenced by clinical  observations12–15. However, the mechanism of SARS-CoV-2-induced damage 
of ECs remains an open question, hypothesizing direct infection of ECs by the virus and their subsequent injury 
or indirect mechanisms originating, for example, from immune  processes16. This issue is fueled by contradictory 
data on the presence of ACE2 receptor on  ECs4,16–23, and the potential viral infection of these  cells24–27. Some 
studies indicate that ECs can be a direct target of SARS-CoV-2 infection. Post-mortem histological analysis evi-
denced a direct viral infection of ECs and diffuse endothelial  inflammation25,26. Moreover, SARS-CoV-2 viremia 
was recently  reported28 and patients with measurable levels of the SARS-CoV-2 RNA in serum were identified 
to be at a higher risk of progression to a critical disease and  death29. However, the other studies suggest that ECs 
are resistant to infection with the SARS-CoV-2  virus16,27, and the vascular dysfunction seen in severe COVID-19 
may be a result of circulating inflammatory mediators released by other infected  cells27.
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ECs are covered by the glycocalyx, a sugar-rich brush layer that tightly overlays the luminal surface of the 
 endothelium30. The glycocalyx is composed mainly of glycoproteins and proteoglycans that form a protective 
shell surrounding the  cell31. The glycocalyx is the first line of cellular defence against infection. However, some 
of the molecules building glycocalyx also play a role as receptors in intercellular interactions, including interac-
tion with  viruses32–36. Heparan sulfate (HS) is the component of glycocalyx contributing to the interaction with 
coronaviruses as a co-receptor in epithelial  cells37. In the context of the SARS-CoV-2 infection, it was reported 
that HS proteoglycans promote the interaction of S-protein with ACE2 and are required for SARS-CoV-2 virus 
binding and infection of epithelial cells, alveolar macrophages and dendritic  cells28,29. Additionally, heparin 
blocked SARS-CoV-2 infection of epithelial cells and alveolar  macrophages28. However, the role of the glycocalyx 
in the binding of SARS-CoV-2 to endothelium and its relation to ACE2 binding is still unclear and understudied.
Adhesive interactions in biological systems can be monitored using the force spectroscopy method with an 
atomic force microscope (AFM). For many years, AFM based force-spectroscopy has been used to monitor the 
interactions between individual cells (single-cell force spectroscopy, SCFS)40,41 or to study the bonds between 
individual molecules (single-molecule force spectroscopy SMFS)42. Moreover, very recently, it was demonstrated 
that single-molecule AFM force spectroscopy could be used to investigate molecular interaction and inhibition 
of SARS-CoV-2 binding to the ACE2 receptor for A549  cells43.
In this work, by using the AFM force spectroscopy method, we directly measured the adhesive interactions 
between the S-protein of SARS-CoV-2 and the surface of ECs. In particular, we focused on the interaction with 
the ACE2 receptors and the role of the cellular glycocalyx either as a shield or as a potential co-receptor for 
the S-protein binding. For this purpose, we used a colloidal AFM probe decorated by S-protein as a sensor for 
both glycocalyx detection and monitoring the adhesive interaction of S-protein with the cell surface. The use 
of the same AFM probe enabled us to simultaneously perform cell elasticity analysis, which is a relatively novel 
biomarker of endothelial dysfunction.
Results
To examine the presence of ACE2 in human ECs, primary human pulmonary artery ECs (HPAECs) transfected 
with non-targeting (siMock) or ACE2-targeting (siACE2) siRNA (Fig. 1a) were stained with anti-ACE2 antibody 
(Fig. 1b,c). The staining confirmed the presence of ACE2 in HPAECs. Compared to human bronchial epithelial 
cells (HBECs), the level of ACE2 in HPAECs was significantly lower (Fig. 1d,e). Moreover, unlike in HBECs, the 
surface distribution of ACE2 in HPAECs was uniform (Fig. 1d).
To address the question of potential SARS-CoV-2 interaction with ECs, the adhesive interactions between the 
S-protein of SARS-CoV-2 and EC surface were measured. We designed a protocol that is illustrated in Fig. 2a. 
A spherical AFM probe with a radius of approximately 1 µm was covered with S-protein. This relatively large 
Figure 1.  Examination of the presence of ACE2 in human ECs. (a) Expression of ACE2 in siMock and siACE2-
transfected HPAECs. (b,c) Immunofluorescent staining of HPAECs transfected with ACE2-targeting (siACE2) 
and non-targeting (siMock) siRNA, with anti-ACE2 antibody. Representative photographs and quantitative 
analysis of immunofluorescence intensity. (d,e) Immunofluorescent staining of ACE2 in HPAECs and HBECs. 
Representative photographs and quantitative analysis of immunofluorescence intensity. Statistics: p values were 
determined by one-way ANOVA followed by Tukey’s post-hoc test. Figure created with OriginPro2021 (https:// 
www. origi nlab. com/ 2021) and ImageJ 1.53e (https:// imagej. nih. gov/ ij/).
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probe diameter, which is an order of magnitude larger than the size of SARS-CoV-2 virus, enables the enhance-
ment of the adhesion signal. Simultaneously, the probe diameter is still small enough to obtain spatially resolved 
information at a length scale of a single EC. Moreover, using a spherical probe with a large diameter allowed 
us to sense and characterize the structural parameters of the soft glycocalyx layer for the same sample areas.
An exemplary experimental force curve (Fig. 2b) represents the time-dependence of the force that acts on 
the AFM probe during approach and retract processes. From the approach part of the curve, the effective elastic 
modulus of the cell (E) and the length (L) of glycocalyx are extracted using Hertz and Alexander-de Gennes 
 models44, respectively. Adhesion parameters  (Fmax—maximum detachment force, N—number of rupture events) 
are derived from the fragment of the curve measured in the retracting phase.
To verify the sensitivity of the setup to S-protein/ACE2 interaction, we performed measurements for HBECs, 
for which strong adhesive interactions can be  expected39. Since the S-protein binding to ACE2 receptors plays 
a pivotal role in the SARS-CoV-2 entry to the host cell, we used the anti-ACE2 blocking antibody (the same 
one which was used for the immunofluorescent detection of ACE2, Fig. 1) to prevent the specific interaction of 
S-protein with ACE2 receptors.
A statistically significant decrease of the mean value of  Fmax denotes the sensitivity of the setup to S-protein/
ACE2 interaction (for histograms of other parameters, maximal detachment force, rupture events, work of 
detachment, elastic modulus and glycocalyx length, see Supplementary Figure 1). Next, low molecular weight 
heparin (LMWH), which has a very similar structure to HS, was used as a non-specific blocker of S-protein38. 
Simultaneous preincubation of the probe and cells with heparin reduced the mean detachment force to the 
level similar to that observed after ACE2 blocking with the antibody (Fig. 3a,b, Supplementary Table 2). The 
height map (Fig. 3c) and adhesive maps shown in Fig. 3d indicate that for native cells, the adhesive events were 
mainly recorded around the central part of the cells, in the perinuclear area, which was determined from the 
height map. After the addition of ACE2 blocking antibody or heparin, in both systems, a significant reduction 
of adhesive events was directly visible on the adhesive maps (Fig. 3d). Interestingly, the distribution of ACE2 on 
HBEC surface was not uniform. High ACE2 density was observed close to the nucleus, but in this region ACE2 
staining colocalizes with glycocalyx, which is not the case in the perinuclear area more distal from the nucleus 
(Fig. 3e,f). It shows, that ACE2 may remain uncovered by glycocalyx in some parts of epithelial cells.
Contrary to HBECs, incubation of HPAECs with ACE2 blocking antibody had no significant effect on the 
maximum detachment force (Fig. 3g,h). A decrease in the adhesion between S-protein and the cell surface was 
observed in response to the heparin pretreatment. (simultaneous pretreatment of the probe and cells) (Fig. 3g–j, 
Supplementary Figure 2, Supplementary Table 2). Importantly, the inhibition of S-protein interaction with 
ECs was not related to the potential heparin-induced increase in glycocalyx length, since the preincubation of 
the probe only, but not HPAECs only, with heparin, decreased the maximal detachment force (Supplementary 
Figure 3). Spatially resolved maps of adhesion parameters showed much weaker spatial dependence of the adhe-
sion parameters, with a much less pronounced increase of the adhesion in the perinuclear area, relatively to the 
nuclear region (Fig. 3i,j). It corresponds with the uniform coverage of ACE2 and glycocalyx on the EC surface 
(Fig. 3k). Comparison of mean fluorescence intensity is shown in Fig. 3l.
To directly investigate whether a controlled degradation of the glycocalyx leads to a reduction of adhesive 
interactions, the enzyme heparinase was applied. Heparinase selectively sheds HS from the cell surface. Before 
AFM measurements, the reduction of HS by heparinase, and the ACE2 level was verified using fluorescence 
microscopy. Representative images of HS and ACE2 staining (Fig. 4a) and quantitative comparison (Fig. 4b) 
indicate a significant reduction of HS, confirmed by the AFM measurement of the glycocalyx length (L = (333 ± 3) 
nm vs (177 ± 8) nm, native vs heparinase, respectively), and an increase of ACE2 level on the HPAEC surface in 
Figure 2.  Experimental design and characterization of studied HBEC and HPAEC cells. (a) The idea of the 
experimental setup. Multiple spike proteins are attached to a large spherical AFM probe that is approached 
to the cell surface. Inset: Optical image of the experimental setup with a spherical probe. The AFM cantilever 
with a probe and HBEC cells on the glass are immersed in the HBSS solution. (b) Time diagram of recording 
a single force-distance curve with the approach, contact and retract regions. In the approach part, regions of 
curves taken for analysis of glycocalyx parameters (blue) and cell elasticity (red) are schematically marked. The 
maximal de-adhesive force and rupture events are marked on the retracting part of the curve. Figure created 
with OriginPro2021 (https:// www. origi nlab. com/ 2021) and Corel Draw2020 (https:// www. corel draw. com/ pl/).
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response to heparinase treatment. The specificity of staining of heparinase-induced ACE2 exposure was con-
firmed with siRNA against ACE2 (Fig. 4c,d).
For AFM measurements, the experiments with heparinase were carried out in two steps. At first, force-
distance curves were collected for cells incubated with heparinase for selective glycocalyx removal. Subsequently, 
heparinase-preincubated cells were treated with anti-ACE2 blocking antibody to inhibit the specific interaction of 
S-protein with ACE2 receptors. Control experiments were done on native cells. The cumulative results obtained 
for all measured cells are shown in the form of histograms of maximum detachment force, and a number of 
rupture events (Fig. 4e–j). Insets in plots show selected spatially resolved maps (25 µm × 25 µm) of maximum 
adhesion force and a number of rupture events. Each histogram from the insets was constructed from multiple 
maps (Supplementary Table 1). Reduction of the glycocalyx layer by heparinase led to a decrease of the adhesive 
force (Fig. 4e–g) and a simultaneous increase in the number of rupture events (Fig. 4h–j). Contrary to cells with 
the intact glycocalyx, for cells pretreated with heparinase, ACE2 blocking caused a significant decrease in the 
adhesion force and the number of rupture events (Fig. 4e–j).
Finally, the functional changes in the cells reflected the augmentation of the specific interactions of S-protein 
with ACE2 after the reduction of the glycocalyx. To verify our observations, we incubated HPAECs with S-protein 
and evaluated the cell elasticity with an uncovered AFM probe. Incubation of HPAECs with S-protein increased 
the cell membrane stiffness and actin polymerization only when the cells were pretreated with heparinase (Fig. 5).
Discussion
In this paper, we confirmed the presence of ACE2 protein in ECs and revealed a significant role of the glycoca-
lyx in the regulation of the binding of SARS-CoV-2 S-protein to the EC surface. In our experiments, multiple 
S-proteins were attached to a micron-sized probe, which enabled adhesive signal enhancement. Still, the AFM 
probe size was small enough to get spatially resolved information and directly sense the delicate glycocalyx layer. 
Therefore, this experimental design resembles typical setups for single-cell  spectroscopy40 rather than single-
molecule force  spectroscopy45–47, which has been very recently applied to study the molecular interaction and 
inhibition of SARS-CoV-2 S-protein binding to the ACE2 receptor on A549  cells43.
We validated our experimental AFM setup on epithelial cells (HBECs). Results presented in Fig. 3a show the 
sensitivity of interaction between S-protein and ACE2 receptor, which is the principal mechanism responsible 
for the entry of the SARS-CoV-2 into airway epithelial cells. Blocking of the ACE2 receptor with anti-ACE2 
antibody significantly reduced the total adhesion force. Spatially resolved adhesive maps collected for the native 
cells illustrate the accumulation of adhesive events in the perinuclear part of the cell, which may indicate recep-
tor clustering. This agrees with the observed non-uniform spatial distribution of glycocalyx and high expression 
of ACE2 on HBECs. The receptor clustering increases the effectiveness of viral infection by raising the prob-
ability of virus binding and its entry to the cell. Blocking of S-protein with heparin decreased the total adhesion 
from (286 ± 12) pN to a value of (121 ± 6) pN. A similar effect was very recently reported for different types of 
epithelial  cells39.
Our study revealed that the characteristics of the interaction of the S-protein with ACE2 differ between 
endothelial cells and epithelial cells. For ECs we observed uniform distribution of the glycocalyx layer, and low 
expression of ACE2 receptors. AFM measurements performed for HPAECs showed that blocking of ACE2 with 
anti-ACE2 does not change the S-protein binding to the EC surface. After blocking, a value of  Fmax = (190 ± 4) pN 
was observed, which was not statistically different from the value for native cells  (Fmax = (195 ± 2) pN). However, 
similarly to the HBECs, the addition of heparin blocked the interaction of S-protein with HPAEC surface, which 
denotes that for native ECs, the ACE2 protein had no measurable effect on S-protein adhesion. A similar effect 
was previously observed for HCoV-NL63  coronavirus37. Also, a very recent preprint, based on an in vitro study, 
suggested a resistance of native ECs to SARS-CoV-2, which is consistent with our  observations27.
To explain this nonintuitive lack of the interaction of S-proteins with ACE2 for native ECs, we treated the cells 
with heparinase. Heparinase can selectively remove heparan sulphate, the main component of the endothelial 
glycocalyx. We hypothesized that the intact endothelial glycocalyx shields the ACE2 receptors. The glycocalyx is 
a dense, negatively charged brush surrounding the cell and forms a protective shield that may block the adhesive 
interaction with receptors located underneath. HS component of the glycocalyx has a global negative charge 
Figure 3.  Differences in adhesive interactions between the S-proteins of SARS-CoV-2 and the surfaces of 
human bronchial epithelial cells (HBECs) and human pulmonary artery endothelial cells (HPAECs). (a) 
Histograms of the maximal detachment force  Fmax for HBECs. Left: comparison of data for native and anti-
ACE2 treated cells. Right: comparison of data for native and heparin treated system. (b) Comparison of mean 
values determined from histograms. (c) AFM height map measured for a single HBEC cell. (d) Corresponding 
adhesive maps measured for this cell. Left: native cell. Middle: anti-ACE2 treatment. Right: heparin treatment. 
(e) Fluorescent staining of ACE2 (green, left column), glycocalyx (Glx, red, middle column) and Merged (right 
column). (f) Quantitative data of ACE2 and Glx mean fluorescence intensity. (g) Histograms of the maximal 
detachment force  Fmax for HPAECs. Left: comparison of data for native and anti-ACE2 treated cells. Right: 
comparison of data for native and heparin treated system. (h) Comparison of mean values determined from 
histograms. (i) AFM height map measured for a single HPAEC cell. (j) Corresponding adhesive maps measured 
for this cell. (k) Fluorescent staining of ACE2 (green, left column), Glx (red, middle column) and Merged (right 
column) (l) Quantitative data of ACE2 and Glx mean fluorescence intensity. Left: native cell. Middle: anti-ACE2 
treatment. Right: heparin treatment. Statistics: p values were determined by one-way ANOVA followed by 
Tukey’s post-hoc test. Experimental details are listed in Supplementary Table 1. Source data are provided as a 
Source Data file. Figure created with OriginPro2021 (https:// www. origi nlab. com/ 2021), ImageJ 1.53e (https:// 
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Figure 4.  Removal of heparan sulfate from glycocalyx reduces the overall adhesion of S-protein to HPAECs 
but exposes ACE2 receptors for binding. (a) Fluorescence staining of HS (red, left column) and ACE2 receptors 
(green, right column) performed for native (top row) and heparinase (Hase) treated HPAECs (bottom row). (b) 
Quantitative data of HS and ACE2 mean fluorescence intensity. (c,d) Fluorescent staining of ACE2 in siMock 
and siACE2-transfected HPAECs treated with heparinase. Representative pictures and quantitative data. (e,h) 
Histograms of adhesive parameters for native cells (grey) and heparinase treated cells (green). (f,i) Histograms 
of adhesive parameters for heparinase treated cells (green) and heparinase treated cells successively incubated 
with anti-ACE2. (g,j) Comparison of mean values. Left: plots for maximal detachment force. Right: plots for the 
number of rupture events. In all histograms and insets show selected spatially resolved maps (25 µm × 25 µm). 
Statistics: p values were determined by one-way ANOVA followed by Tukey’s post-hoc test. Experimental details 
are listed in Supplementary Table 1. Source data are provided as a Source Data file. HS heparan sulfate, Hase 
heparinase, anti-ACE2 ACE2 blocking antibody, Glx glycocalyx. Figure created with OriginPro2021 (https:// 
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and therefore, can interact electrostatically with the viral S-proteins by binding with the positively charged 
domain of S-protein39. Simultaneously, for native “healthy” ECs the glycocalyx is long enough (L = (333 ± 3) nm 
according to Supplementary Figure 3 and Supplementary Table 2) to block the direct contact of S-protein and 
ACE2 membrane receptors that are directly anchored to the cell surface. Removal of HS from the endothelial 
glycocalyx by heparinase treatment confirmed our hypothesis. First, the removal led to a significant reduction 
in the total adhesion force. At the same time, the number of rupture events raised, which denotes an increase 
in specific interactions, likely with the ACE2 receptor. This is confirmed by the fluorescent staining of HS and 
ACE2, where also an effect of the glycocalyx reduction and an increased expression of ACE2 receptors can be 
observed. Most importantly, for cells pre-incubated with heparinase and with a partially removed glycocalyx, a 
successive blocking of ACE2 with anti-ACE2 resulted in a significant decrease of the maximum detachment force. 
This means that for the ECs with impaired glycocalyx, the interaction of S-protein and ACE2 is considerable.
Moreover, the results from the elasticity measurements (Fig. 5) indicate that the response of HPAECs to incu-
bation with S-protein depends on the glycocalyx condition. Removal of HS from the glycocalyx layer strongly 
increased HPAEC stiffness, which correlated with the actin polymerization. EC stiffening is one of the symptoms 
of endothelial dysfunction, as it was shown in our previous  papers48,49. The stiffening of HPAECs after incuba-
tion with S-protein can be indirectly linked with an onset of the endocytosis process, which takes place during 
SARS-CoV-2 entry into the cell. The binding of a specific ligand to the ACE2 receptors was shown to trigger 
internalization of the  receptor50,51. In accordance, it was demonstrated that S-protein activates the ACE2 mediated 
cellular endocytosis signal pathway, by which SARS-Co-V enters the susceptible  cells52. The endocytosis process 
induces the actin cytoskeleton polymerization and engages the actin fibers in multiple steps of internalization, 
Figure 5.  Endothelial cells stiffening after incubation with S-protein is more pronounced for cells with 
removed glycocalyx. (a) Elastic modulus of HPAECs for native cells (grey histogram) and for cells incubated 
with S-protein (magenta). (b) Mean fluorescence intensity of phalloidin (AlexaFluor488). (c) Examples of 
fluorescence images depict the actin structure in native HPAECs and after incubation with S-protein. Green—
actin. Blue—nucleus. (d) Examples of AFM-QI images of native HPAECs and after incubation with S-protein. 
(e) Elastic modulus obtained for HPAECs pre-incubated with heparinase (green) and next incubated with 
S-protein (magenta). (f) Mean fluorescence intensity of phalloidin (AlexaFluor488) after removal of HS. (g) 
Fluorescence images show the actin polymerization that occurred after incubation with S-protein for HPAECs 
pre-incubated with heparinase. (h) Examples of AFM-QI images depict the changes of cell morphology and 
cortical actin network after incubation with S-protein for HPAECs pre-incubated with heparinase. Statistics: 
p values were determined by one-way ANOVA followed by Tukey’s post-hoc test. Figure created with 
OriginPro2021 (https:// www. origi nlab. com/ 2021), ImageJ 1.53e (https:// imagej. nih. gov/ ij/) and JPK Data 
Processing 6.1.79 (https:// www. jpk. com/).
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endosomal sorting, and trafficking of viral particles in  ECs50. In our experiments, for native ECs with a well-
preserved glycocalyx layer, the addition of S-protein did not change the elastic modulus. Evaluation of the cell 
elasticity strengthened the hypothesis, that glycocalyx, by the strong binding of S-protein to HS, can prevent the 
interaction of S-protein with ACE2 receptors in ECs.
The influence of glycocalyx on the interaction between S-protein and ACE2 is of particular importance. Due to 
its location, the glycocalyx is the first target of the virus interaction, and therefore this interaction could determine 
the virus entry to the host cell. In this work, we have shown a dual role of the endothelial glycocalyx in control of 
the virus adhesion and interaction with ACE2 receptors. For healthy endothelium, the well-preserved glycocalyx 
layer promotes the overall adhesion of S-protein to the cell surface and acts as an “anchor”53. However, at the 
same time the rich endothelial glycocalyx screens the S-proteins from the ACE2 receptors. For well-preserved 
glycocalyx, ACE2 expression is low and glycocalyx acts as a structural barrier. For impaired glycocalyx, though 
the total adhesion of S-protein to the cell surface is decreased, the structural barrier formed by the glycocalyx 
is lowered and ACE2 expression is upregulated. Hence, endothelial cells might be more susceptible to the virus 
entry. Significantly, endothelial dysfunction, which is present in inflammation, and cardiovascular disease, diabe-
tes and endothelial ageing is usually related to glycocalyx  impairment40,44. The presence of the above comorbidi-
ties may worsen the prognosis, frequently causing a severe COVID-19 coarse and might often cause of  death5. 
Our results indicate that the reduction of endothelial glycocalyx may explain those observations.
Concluding, glycocalyx has the main contribution to the attachment of viral S-protein to ECs. Simultane-
ously, glycocalyx shields the S-protein interaction with ACE2 whereas its removal exposes ACE2 on the cell 
surface. In our experiments, we monitored the adhesion of isolated S-proteins at short time scales. Therefore, the 
results should be benchmarked with studies for active viruses. However, the increased number of reports that 
SARS-CoV-2 virus penetrates the bloodstream and may directly affect the endothelium make this observation 
of particular importance.
Methods
Cell culture. Primary Human Bronchial Epithelial Cells (HBECs, ATCC) cells were cultured in Airway Epi-
thelial Cell Basal Medium (Cat. No. PCS-300-030, ATCC) supplemented with Bronchial Epithelial Cell Growth 
Kit (Cat. No. PCS-300-040, ATCC). Primary Human Pulmonary Artery Endothelial Cells (HPAECs, ATCC) 
were grown in Vascular Cell Basal Medium (Cat. No. PCS-100-030, ATCC), supplemented with Endothelial Cell 
Growth Kit-VEGF (Cat. No. PCS-100-041, ATCC) The cells were maintained in standard conditions at 37 °C, 
5%  CO2, and 95% humidity.
Transfection with small interfering RNA. Transfections of HPAECs were performed using 20  nM 
siRNA targeted against human ACE2 (Life Technologies, s11056) or mock siRNA (Life Technologies; Negative 
Control #2) using Lipofectamine™ RNAiMAX Transfection Reagent (Life Technologies, s33966) in Opti-MEM I 
Reduced Serum medium (Life Technologies). The cells were used for the experiments at 48 h after transfection.
Quantitative RT‑PCR. RNA was isolated using RNeasy Mini Kit (Qiagen). Reverse transcription reaction 
was made using High Capacity cDNA Reverse Transcription Kit (Life Technologies). The procedures were per-
formed according to the manufacturer’s instructions. Quantitative RT-PCR was performed using StepOnePlus 
real-time PCR system (Applied Biosystems) with SYBR Green PCR Master Mix (Sigma-Aldrich). Sequences of 
used primers: hACE2 F: GGA CCC AGG AAA TGT TCA GA R: GGC TGC AGA AAG TGA CAT GA; hEEF2 F: TGA 
GCA CAC TGG CAT AGA GGC R: GAC ATC ACC AAG GGT GTG CAG.
QI‑AFM imaging. HBEC and HPAEC AFM imaging was performed using V-shaped gold-coated cantile-
vers (MLCT, Bruker) with nominal spring constant of 0.03 N/m. All experiments were performed for non-fixed 
cells in Hanks’ Balanced Salt Solution (H8264, Sigma-Aldrich). Images (128 × 128 pixels) were obtained at scan 
size of 20 × 20 μm2 for HBECs and 40 × 40 μm2 for HPAECs. Topographical images were performed using force-
distance (FD)–based imaging mode (QI; JPK Instruments) allowing for high-resolution imaging of living cells. 
In this method, single FD-curve is performed in every pixel point of the image and then translated from the 
selected trigger force into images of cell topography. The loading force used varied from 0.8 to 1.4 nN and was 
adjusted to obtain a clear contrast of the cell surface. The obtained images of topography were analyzed using 
JPK Data Processing Software.
AFM probe covering with S‑proteins. For measurement, we used spherical glass probes, with a radius of 
1.25 μm, attached to a flexible cantilever with the spring constant of 0.02 N/m (Novascan). First, each probe was 
cleaned with ethanol and  dH20, then incubated with 10% APTES (Sigma Aldrich) in  dH20 for 20 min at room 
temperature (RT). After this time, probes were rinsed accurately three times with  dH20 and were immersed in 
2.5% Glutaraldehyde (Sigma Aldrich) for 15 min. Next, the probes were rinsed in  dH2O and immersed in 50 ng/
mL Anti-His-Tag (BioVision) solution (PBS) for 15 min at RT. At the end, the probes were incubated with 50 ng/
mL Recombinant Coronavirus Spike Protein (SARS-CoV S1, His-Tag, BioVision) solution for 30  min. Each 
probe was very gently rinsed and immediately taken for measurements. One S-protein covered probe was used 
for experiments on a maximum 4 cells (Supplementary Figure 5).
Force‑distance curve measurement. For AFM experiments, HPAECs or HBECs were seeded at a den-
sity of  104 cells/mL on a round glass coverslip and then cells were grown for 48 h. Next, the sample with cells was 
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gently mounted into AFM liquid cell (BioCell, JPKInstruments) and measured in Hanks’ Balanced Salt Solution 
(HBSS, Sigma-Aldrich) supplemented with 4.5 mM glucose at stable temperature 36.2 °C.
All AFM measurements were performed using a NanoWizard 3 NanoScience AFM (JPK Instruments). Meas-
urements were conducted using a force mapping mode. For each cell, a spatial map of force vs distance (FD) 
curves at a grid of 7 × 7 or 16 × 16 points was measured. The size of the grid corresponds to a square surface with 
dimensions from 10 μm × 10 μm to 25 μm × 25 μm. The resulting step size of approx. 1.5 μm was chosen to be 
comparable with the probe diameter. The position of scan areas was controlled by inverted optical microscopy 
(Olympus). Force-distance curves were measured at a speed of 2 µm/s. The contact time was 1 s, and the maximal 
applied force was 500 pN (Supplementary Figure 4). Before and after a series of force-distance measurements, 
calibration of cantilever spring constant was performed by using Nanowizard software.
To evaluate changes of the elastic modulus of HPAEC after incubation with S-protein, AFM measurements 
were performed with a non-covered spherical polystyrene AFM probe with a radius of 2.2 μm (Novascan) 
mounted on the triangular cantilever with the spring constant 0.03 N/m.
Force‑distance curve analysis. To determine the cell elastic modulus E and glycocalyx length L, we used 
a procedure proposed by Sokolov et al.54. As described in our recent  papers41, the Hertz model was fitted to the 
part of the curve close to the maximal indentation, for which the glycocalyx is assumed to be almost squeezed. 
According to Alexander-de Gennes theory, the steric polymer brush model was fitted to the data to calculate 
the length of the glycocalyx layer. The parameters were derived using software written in Matlab environment.
The adhesive parameters were obtained by the analysis of the retract part of force-distance curves by using 
JPKSPM Data Processing software. Maximal detachment force  Fmax was calculated as the outermost point on the 
retraction curve with respect to the baseline. The parameter  Fmax corresponds to the force required to detach the 
probe covered S-protein from the cells surface and reflects the non-specific interaction as well as the specific inter-
action of S-protein with the cells surface. Rupture events are defined as characteristic unbinding jumps recorded 
on the FD curve associated with the breakage of specific bonds between membrane receptors and the S-protein.
Design of AFM experiments. At first, the native cells were measured. To block the specific interactions, 
a 100  ng/mL anti-ACE2 (BioVision) blocking antibody solution was added to the native cell and incubated 
for 20 min in AFM liquid cell. After this time, the buffer was replaced, AFM probe coated with S-protein was 
mounted and the force-distance (FD) curves were immediately measured. To block S-proteins, the AFM probe 
covered with S-protein and cells were exposed to 50  U low molecular weight heparin (LMWM, Sigma) for 
30 min. After this time, FD curves were measured. For reduction of glycocalyx layer, 100 U Heparinase I/III 
(Sigma) was added to the native cells immersed in HBSS and incubated for 45 min at 36.2 °C in AFM liquid cell. 
After this time, the buffer was replaced and the AFM measurement started. In the end, the anti-ACE2 was added 
to block the ACE2 receptors. All experiments were repeated two or three times, as described in Supplementary 
Table 1.
Heparan sulfate and ACE2 staining of HPAECs. 48  h before the experiment, cells were seeded on 
coverslip coated with 0.1% gelatin (Sigma). At the experimental day, cells were incubated with 10 U heparinase 
(Sigma Aldrich) for 3 h. After treatment, cells were washed with PBS and then fixed with 4% paraformaldehyde 
solution in PBS (ChemCruz) for 10 min in RT. Next, cells were briefly washed 3 times with PBS and blocked for 
1 h in RT with a blocking solution containing 5% BSA (Sigma) in PBS. Then cells were incubated O/N with I 
antibody against HS (1:100, Amsbio cat. clone F58-10E4) and ACE2 (1:100, BioVision) in blocking solution at 
4 °C. Next day, cells were washed 3 times with PBS (5 min, RT) and incubated with II antibody conjugated with 
a fluorophore (1:500) (Life Technologies), subsequently counterstained with DAPI (Sigma Aldrich) in blocking 
solution for 1 h at RT. After this step, cells were washed 3 times with PBS (5 min, RT), mounted with DAKO 
Mounting Medium (Dako) to the glass slides and analyzed with a meta laser scanning confocal microscope 
(LSM-880; Carl Zeiss). The fluorescence intensity data was measured by using ImageJ2x software.
Glycocalyx visualization. 48 h before the experiment, cells were seeded on coverslip coated with 0.1% 
gelatin (Sigma). After the appropriate time, cells were fixed with paraformaldehyde (3.8%, Sigma) for 10 min. 
Next, cells were gently rinsed in PBS three times and incubated with blocking peptide solution (Santa Cruz 
Biotechnology) for 30 min. After this time, they were washed three times in PBS and incubated with wheat germ 
agglutinin (Wheat Germ Agglutinin, Alexa Fluor™ 555 Conjugate, Invitrogen) for 30 min.
Actin staining of HPAEC. HPAECs were grown on a coverslip coated with 0.1% gelatin (Sigma) for 48 h. 
Before staining, the culture medium was removed, the cells were rinsed with PBS and then fixed with 3.6% 
formaldehyde (Sigma) for 10 min in room temperature. Next, the cells were rinsed three times with buffer and 
permeabilized with 0.1% Triton X (Invitrogen-ThermoFisher) for 4 min, followed by blocking in PBS contain-
ing 1% BSA (Invitrogen-ThermoFisher) for 30 min. After this time, cells were rinsed with PBS and incubated 
with phalloidin conjugated with Alexa Fluor 488 dye (1:8000, Molecular Probes) for 20 min and counterstained 
with Hoechst (Sigma Aldrich) for 5 min at RT. Before the measurement, cells were rinsed twice with PBS and 
mounted with DAKO Mounting Medium (Dako) to the glass slides. Fluorescence images were obtained using 
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Statistical analysis. The force spectroscopy AFM data and nanoindentation data were presented in the 
form of histograms. The bar size for maximal adhesion force is 20 pN. The mean values were calculated based 
on a log-normal distribution fit, and presented as a mean value ± SD. The fluorescence intensity data of HS and 
ACE2 were presented in the form of box-plot; each point corresponds to the fluorescence intensity of single-cell 
normalized to the cell surface. For phalloidin, the fluorescence intensity was measured for all image and nor-
malized to the number of cells. The data were presented as a mean value ± SD. Statistical significance was tested 
using single-way ANOVA (P < 0.05) followed by Tukey’s mean comparison tests. Since the AFM data were log-
normally distributed, we performed data transformation using a natural logarithm, in order to use the ANOVA 
statistical test. In the manuscript, all data was shown as non-transformed raw data. All statistical analysis and 
graphs are prepared in Origin.
Data availability
The source data underlying Figs. 3a,g, 4b,e,h,f,i, 5a,b,e,f and Supplementary Figures 1 and 2 are provided as a 
Source Data file. All other relevant data are available from the corresponding authors upon reasonable request.
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